TBPH Annual Cost Of Goods Sold
N/A
31 December 2023
Summary:
TBPH annual cost of goods sold is not available.TBPH Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TBPH Quarterly Cost Of Goods Sold
N/A
30 September 2024
Summary:
TBPH quarterly cost of goods sold is not available.TBPH Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TBPH TTM Cost Of Goods Sold
N/A
30 September 2024
Summary:
TBPH TTM cost of goods sold is not available.TBPH TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TBPH Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
TBPH Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Theravance Biopharma Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $715.00 K(-88.1%) | $632.00 K(-10.4%) | $715.00 K(-77.6%) |
| Sept 2018 | - | $705.00 K(-148.7%) | $3.20 M(-8.0%) |
| June 2018 | - | -$1.45 M(-275.3%) | $3.48 M(-44.7%) |
| Mar 2018 | - | $826.00 K(-73.5%) | $6.29 M(+4.3%) |
| Dec 2017 | $6.03 M(+108.4%) | $3.12 M(+216.3%) | $6.03 M(+48.5%) |
| Sept 2017 | - | $985.00 K(-27.8%) | $4.06 M(+19.2%) |
| June 2017 | - | $1.36 M(+141.4%) | $3.41 M(+27.1%) |
| Mar 2017 | - | $565.00 K(-50.7%) | $2.68 M(-7.4%) |
| Dec 2016 | $2.89 M | $1.15 M(+245.2%) | $2.89 M(-41.5%) |
| Sept 2016 | - | $332.00 K(-48.0%) | $4.95 M(-4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $638.00 K(-18.0%) | $5.20 M(+2.6%) |
| Mar 2016 | - | $778.00 K(-75.7%) | $5.07 M(+8.7%) |
| Dec 2015 | $4.66 M(+14.8%) | $3.20 M(+450.9%) | $4.66 M(-0.4%) |
| Sept 2015 | - | $581.00 K(+15.0%) | $4.68 M(+4.7%) |
| June 2015 | - | $505.00 K(+36.1%) | $4.47 M(+5.3%) |
| Mar 2015 | - | $371.00 K(-88.5%) | $4.24 M(+4.5%) |
| Dec 2014 | $4.06 M | $3.22 M(+773.2%) | $4.06 M(+385.4%) |
| Sept 2014 | - | $369.00 K(+32.3%) | $836.00 K(+79.0%) |
| June 2014 | - | $279.00 K(+48.4%) | $467.00 K(+148.4%) |
| Mar 2014 | - | $188.00 K | $188.00 K |
FAQ
- What is the all time high annual cost of goods sold for Theravance Biopharma?
- What is the all time high quarterly cost of goods sold for Theravance Biopharma?
- What is the all time high TTM cost of goods sold for Theravance Biopharma?
What is the all time high annual cost of goods sold for Theravance Biopharma?
Theravance Biopharma all-time high annual cost of goods sold is $6.03 M
What is the all time high quarterly cost of goods sold for Theravance Biopharma?
Theravance Biopharma all-time high quarterly cost of goods sold is $3.22 M
What is the all time high TTM cost of goods sold for Theravance Biopharma?
Theravance Biopharma all-time high TTM cost of goods sold is $6.29 M